Submit Manuscript    >>    Login | Register

Brugada syndrome: risk stratification and management


The Brugada syndrome (BrS) is an arrhythmogenic disease associated with an increased risk of ventricular fibrillation and sudden cardiac death. The risk stratification and management of BrS patients, particularly of asymptomatic ones, still remains challenging. A previous history of aborted sudden cardiac death or arrhythmic syncope in the presence of spontaneous type 1 ECG pattern of BrS phenotype appear to be the most reliable predictors of future arrhythmic events. Several other ECG parameters have been proposed for risk stratification. Among these ECG markers, QRS-fragmentation appears very promising. Although the value of electrophysiological study still remains controversial, it appears to add important information on risk stratification, particularly when incorporated in multiparametric scores in combination with other known risk factors. The present review article provides an update on the pathophysiology, risk stratification and management of patients with BrS.

Credits: Konstantinos P. Letsas; Stamatis Georgopoulos; Konstantinos Vlachos; Nikolaos karamichalakis; Ioannis Liatakis; Panagiotis Korantzopoulos; Tong Liu; Michael Efremidis; Antonios Sideris



Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists